ConductScience.org, home

Paper8239587

Anti-Mycobacterium avium activity of quinolones: in vitro activities.

Klopman G and 5 others. Antimicrob Agents Chemother, 1993. Cited by 40 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Anti-Mycobacterium avium activity of quinolones: in vitro activities. Papers, record 8239587. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8239587

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-Mycobacterium avium activity of quinolones: in vitro activities.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1993
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.59
iCite
Revised in PubMed
2021-05-26
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klopman GG
2Wang SS
3Jacobs MRM R
4Bajaksouzian SS
5Edmonds KK
6Ellner JJJ J

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
Mycobacterium avium ComplexMajor topic
Ciprofloxacin
Drug Resistance, Microbial
Humans
Microbial Sensitivity Tests

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
SRC AI 30189NIAID NIH HHSUnited StatesU01AI030189PubMed and NIH

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16,321,736
Structure-activity relationships among DNA gyrase inhibitors. Synthesis and biological evaluation of 1,2-dihydro-4, 4-dimethyl-1-oxo-2-naphthalenecarboxylic acids as 1-carba bioisosteres of oxolinic acid.
J Med Chem1984https://conductscience.org/library/papers/6321736PubMed
26,236,748In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6236748PubMed
33,005,575New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.J Med Chem1986https://conductscience.org/library/papers/3005575PubMed
43,010,848Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other quinolone carboxylic acids.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3010848PubMed
52,940,969Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/2940969PubMed
63,015,000Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosa.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3015000PubMed
73,107,379Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.Am J Med1987https://conductscience.org/library/papers/3107379PubMed
83,121,243In vitro activity of ciprofloxacin and ofloxacin against the Mycobacterium avium-intracellulare complex.Diagn Microbiol Infect Dis1987https://conductscience.org/library/papers/3121243PubMed
9337,300Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/337300PubMed
107,452,690Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids.J Med Chem1980https://conductscience.org/library/papers/7452690PubMed
116,786,770[A new synthetic antibacterial : 1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-1, 4-dihydroquinolin-3-carboxylic acid (1589 R.B.)].C R Seances Acad Sci III1981https://conductscience.org/library/papers/6786770PubMed
126,271,730New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity.J Bacteriol1981https://conductscience.org/library/papers/6271730PubMed
136,960,805In vitro and in vivo activity of DL-8280, a new oxazine derivative.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6960805PubMed
146,222,695In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6222695PubMed
153,501,698Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3501698PubMed
162,829,716Computer automated structure evaluation of quinolone antibacterial agents.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/2829716PubMed
173,138,801Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.Tubercle1987https://conductscience.org/library/papers/3138801PubMed
182,113,793MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2113793PubMed
191,848,296Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.J Med Chem1991https://conductscience.org/library/papers/1848296PubMed
202,002,456Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.J Med Chem1991https://conductscience.org/library/papers/2002456PubMed

See all 27 references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
35,990,901Neighborhood-based inference and restricted Boltzmann machine for microbe and drug associations prediction.PeerJ2022https://conductscience.org/library/papers/35990901PubMed
34,443,431Efficient Regioselective Synthesis of Novel Condensed Sulfur-Nitrogen Heterocyclic Compounds Based on Annulation Reactions of 2-Quinolinesulfenyl Halides with Alkenes and Cycloalkenes.Molecules2021https://conductscience.org/library/papers/34443431PubMed
31,413,045Transferable Mechanisms of Quinolone Resistance from 1998 Onward.Clin Microbiol Rev2019https://conductscience.org/library/papers/31413045PubMed
21,372,133Bacterial conversion of folinic acid is required for antifolate resistance.J Biol Chem2011https://conductscience.org/library/papers/21372133PubMed
10,991,858Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10991858PubMed
10,898,685Antimycobacterial activities of novel levofloxacin analogues.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10898685PubMed
8,913,479N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8913479PubMed
8,913,475Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8913475PubMed
8,891,145Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8891145PubMed
8,727,932New drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay.J Clin Microbiol1996https://conductscience.org/library/papers/8727932PubMed
8,549,419Activity of quinolones against mycobacteria.Drugs1995https://conductscience.org/library/papers/8549419PubMed
8,239,588Anti-Mycobacterium avium activity of quinolones: structure-activity relationship studies.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8239588PubMed
7,986,010In vitro anti-Mycobacterium avium activities of quinolones: predicted active structures and mechanistic considerations.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7986010PubMed
7,872,747A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7872747PubMed
7,793,885Comparison of activities of fluoroquinolones in murine macrophages infected with Mycobacterium tuberculosis.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7793885PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8239587

GET https://conductscience.org/api/papers/v1/8239587/references?page=2